Trials / Completed
CompletedNCT03784170
FemPulse Therapy for Overactive Bladder in Women
Evaluation of a Non-Implanted Electrical Stimulation Continence Device for Overactive Bladder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- FemPulse Corporation · Industry
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
Detailed description
The FemPulse System is a vaginal ring intended to provide mild electrical stimulation to nerves that regulate bladder function. It is believed that stimulation of these nerves may help relieve the symptoms of OAB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FemPulse System | Device therapy with the FemPulse System |
Timeline
- Start date
- 2018-12-11
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2018-12-21
- Last updated
- 2026-02-06
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03784170. Inclusion in this directory is not an endorsement.